A 2% decline in FVC or DLco significantly increases the risk of death or lung transplant in IPF patients, challenging current clinical thresholds. The study suggests that smaller declines in lung ...
Pulmonary function testing serves 2 important clinical goals: (1) categorizing the physiologic impairment from lung disease (ie, obstructive, restrictive, etc) and (2) quantifying the degree of ...